A cure for the herpes simplex virus could be on the horizon after researchers at the Fred Hutch Cancer Center in Seattle say they’ve narrowed down a way to deal with the disease. For Healthier ...

Scientists have hijacked the herpes virus and turned it into a cancer-busting ally. A decade after the United States Food and Drug Administration (FDA) approved the first virus-based cancer therapy, ...

— Dr. David Ginn, Senior VP of Research and Development at Erroll McCoy AUGUSTA, GA, UNITED STATES, December 12, 2024 /EINPresswire.com/ -- Erroll McCoy is excited ...

Interim Data from the Phase 1b portion of the study in participants with recurrent genital herpes is expected in the first half of 2025. Part B of the study will evaluate weekly and monthly oral ...

Ruvidar(TM) demonstrates higher efficacy in the treatment of Herpes Simplex Virus, Type 1 versus FDA-approved, standard of care treatments Acyclovir and Abreva in a preclinical animal model. In the ...

SEATTLE — It is a virus that's been ailing humans for millions of years, but to this day, there has been no absolute cure. Virologists at Fred Hutchinson Cancer Center in Seattle believe they're on ...

Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...

Approximately two-thirds of the world's population under the age of 50 years have oral or genital herpes simplex type 1 (HSV-1) infection, while one in eight have herpes simplex type 2 (HSV-2) ...

Herpes is shockingly common. Recent estimates suggest at least half of all Americans have HSV-1, or oral herpes, which usually manifests as cold sores on or around one’s mouth, but can spread to ...